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Introduction
Cancer cells are able to continuously proliferate, promote 
cell division despite cell damage, and reduce apoptosis 
incidence. Disturbance in apoptosis could disrupt the 
delicate balance between cell proliferation and cell 
death and lead to diseases such as cancer (1,2). In fact, 
evading from programmed cell death is known as one of 
the six essential changes in cell morphology that dictate 
malignant growth and is a hallmark of most, and maybe 
all types of cancer (3). On the other hand, decreased 
incidence of apoptosis in cancer cells makes them 
resistant to the treatment with standard chemotherapeutic 
drugs or agents (4). In gastric cancer like other cancers, 
cell division and apoptosis are disrupted and despite 
improvement in surgical techniques and chemotherapy, 
gastric cancer remains leading cause of cancer-related 
deaths worldwide (5). Because of disturbance in apoptotic 
pathways (6), resistance to chemotherapeutic drugs (7,8), 
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Caffeic acid phenethyl ester (CAPE) prevents growth and proliferation of AGS cells due to apoptotic process. Therefore, CAPE might 
be useful in developing chemotherapeutic agents for treating human gastric cancer.
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Introduction: Gastric cancer is the fourth prevalent cancer and the second reason for cancer-
associated mortalities worldwide. Caffeic acid phenethyl ester (CAPE) is one of the main medicinal 
components of propolis. The aim of this study was to investigate the morphological apoptotic 
changes and cytotoxic effects of CAPE in human gastric adenocarcinoma cell line (AGS cell).
Methods: AGS human gastric cancer cell line was cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) medium in vitro. Cytotoxic effects and morphological changes induced by 72 h 
treatment with CAPE at different concentrations on AGS cells were investigated by MTT assay test 
and inverted microscope, respectively.
Results: CAPE in a concentration dependent fashion reduced viability of AGS cells. IC50 was 
obtained approximately 10 µM at 72 h treatment. Also, CAPE induced concentration-dependent 
morphological apoptotic changes and promoted complete apoptosis program in AGS human 
gastric cancer cell line.
Conclusion: Our results strongly suggest that CAPE stimulates apoptotic process and leads to 
cell death. Therefore, CAPE could be useful in developing chemotherapeutic agents for treating 
human gastric cancer.
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recurrence of tumor or lymph node metastasis of gastric 
cancer after surgery (9,10), effort for improvement of 
survival in gastric cancer patients is obviously needed. 
Therefore, prevention of uncontrolled proliferation and 
restore programmed cell death with possible drugs are 
useful and practical methods of preventing cancer and 
treating gastric cancer, and developing such drugs could 
efficient against gastric cancer.
Fundamentally, apoptotic cells are distinguished from 
normal and necrotic cells by certain morphological 
characteristics and these characteristics have remained an 
important tool in apoptosis research. These characteristics 
include cell rounding and shrinkage, membrane blebbing, 
chromatin condensation, nuclear fragmentation, and 
apoptotic body formation. Indeed, Kerr et al. coined the 
term apoptosis to describe a particular morphological 
aspect of cell death and it remains a morphological 
description (11). On the other hand, the results of 
biochemical approaches such as DNA laddering 
considerably vary based on cell type (12). Therefore, 
approaches that describe morphological specifications 
and detect the existence of apoptosis correctly are widely 
used in studies of tissue growth and some diseases.
Propolis is a natural product and a promising source for 
discovering new drugs (13). Caffeic acid phenethyl ester 
(CAPE) is a pharmacologically important compound of 
propolis and has significant biological activities such as 
antibacterial, antiviral, anti-inflammatory, anticancer, and 
is a well-known and well-documented inhibitor of the 
transcription factor nuclear factor kappa B (NF-ĸB) (14-
21). CAPE is believed to be fundamentally responsible 
for anticancer activities of propolis and its anticancer 
properties have been confirmed in some cancer models 
such as colon cancer, lung cancer, melanoma, glioma, etc. 
In this study, the cytotoxic effects of CAPE on viability of 
AGS human gastric cancer cells and also especial effects 
on induction of morphological apoptotic changes in these 
cells were evaluated. 
Materials and Methods
Chemicals and reagents
Culture medium of DMEM, fetal bovine serum (FBS), 
penicillin-streptomycin, and trypsin-EDTA were 
purchased from Gibco Co (Invitrogen, Carlsbad, 
CA, USA). CAPE and dymethyle sulfoxide (DMSO) 
were purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay Kit was purchased 
from BIO IDEA Co (Tehran-Iran). CAPE at 100 mM 
concentration was dissolved in DMSO as solvent and 
stored in 100-µl volume at -20 °C temperature.
Cells culture
AGS human gastric cancer cell-line was purchased from 
National Cell Bank of Iran (NCBI), Pasteur Institute of Iran 
(NCBI, C131). The cells were cultured in DMEM medium 
containing 10% FBS and 1% penicillin-streptomycin at 37 
°C temperature in a humidified incubator containing 5% 
CO2. For maintaining the cells in the exponential growth 
phase, they were passaged twice a week. All tests were 
performed in approximately 80% cell confluence.
Cell viability assay
Cell viability was measured by MTT assay kit. The viability 
of AGS cells was measured in different concentrations of 
CAPE within 72 h. Cells were seeded into 96 well plates 
at a density of 5×10^3 cells per well and the plates were 
incubated at 37 °C temperature in a humidified incubator 
containing 5% CO2 for 24 h. After 24 h, the medium was 
removed and the cells were treated for 72 h with medium 
containing different concentrations (0, 10, 15, 20, 30, 40, 
50, 60, 80, and 100 µM) of CAPE. The cells that were 
not treated with CAPE were considered as control. The 
same volume of DMSO was used as the vehicle control 
for CAPE experiments at a final concentration of 0.1%. 
Each CAPE concentration was represented by 3 wells 
and replicated thrice. After 72 h, AGS cells viability was 
measured by MTT Assay kit according to manufacture 
protocol. Finally, optical density (OD) of each well was 
measured by an ELISA reader (AWARENESS-State Fax, 
USA) at 570-nm wavelength and the rate of viability (%) 
was calculated by the following formula:
Cell viability rate (%) = OD of treated cells / OD of control 
cells × 100 
Morphological apoptotic changes in AGS cells
AGS cells were firstly cultured in 96-well plates with 
5×10^3 cells per well in 150 µl for 24 h. After 24-h 
incubation in standard conditions, the cells were treated 
with CAPE at different concentrations in triplicate. The 
cells that were treated with the medium containing 0.1% 
of DMSO were used as control. After 72 h, morphological 
apoptotic changes in the cells treated with CAPE were 
investigated using inverted microscope (Nikon eclipse 
ts100) and compared with control cells. In addition, for 
more closer survey of morphological changes progression 
steps, AGS cells  treated with 60 µM of CAPE was 
investigated for morphological changes within a 72-h 
period once every 12 h.
Statistical analysis
The statistical analysis of MTT assay data for different 
concentrations of CAPE within 72 h that calculated as 
viability percent was done by SPSS 19 using one-way 
ANOVA followed by Dennett’s test. P-value< 0.05 was 
considered as statistically significant.
Results
The effects of CAPE on AGS cells viability 
Analysis of the data on AGS cells treatment with CAPE 
within 72 h indicated that all treated CAPE concentrations 
decreased the AGS cells viability so that the first 
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treatment concentration (10 µM) decreased the viability 
by approximately 50% and was considered as 72-h IC50. 
Other treatment concentrations decreased the viability 
further so that the viability was obtained 38.6, 30.66, 
24.6, 20.33, 13, 5.33, and 1.33 at 15, 20, 30, 40, 50, 60, 
and 80 µM concentrations, respectively while the 100 µM 
concentration decreased cell viability by 100%. Dunnett’s 
test indicated that the decrease in viability was significant 
at all treatment concentrations within 72 h (P< 0.001) 
(Figure 1).
Effect of CAPE treatment on induction of morphological 
changes in AGS cells
Study of control cells using inverted microscope indicated 
that these cells had normal morphological specifications 
and maintained these specifications until the completion 
of treatment steps. It is noteworthy that the morphology 
of a small number of control cells indicated minor 
changes after 72-h incubation, which could be due to 
high density and release of additional metabolic material 
into the medium. Morphological study of the cells treated 
with CAPE within 72-h period indicated that AGS cells 
exhibited different degrees of morphological changes 
including loss of cell adhesion, membrane shrinkage, 
membrane blebbing, cytoplasm vacuolization, formation 
of abnormal cellular wrinkle, cell fragmentation, and 
formation of apoptotic bodies depending on treatment 
concentration.
At lower  concentrations (20 µM and less) of CAPE, the 
changes were less severe and more limited so that cell 
shrinkage and membrane blebbing comprised most 
changes while at 30 µM and higher concentrations, the 
changes were much more severe including cytoplasmic 
swelling, cell fragmentation, and formation of apoptotic 
bodies and finally ended with lysis of these bodies 
(Figure 2). 
Figure 1. Viability of AGS cells in treatment with CAPE at 72 
h. X axis represents 0, 10, 15, 20, 40, 30, 50, 60, 80, and 100 
µM CAPE concentrations and Y axis represents cells viability in 
AGS human gastric cancer cells. As illustrated, AGS cells viability 
decreases depending on CAPE concentration with an IC50 of 
approximately 10 µM.
Figure 2. CAPE induces morphological apoptotic changes in 
AGS cells. The cells were seeded for 24 h and then treated with 
different concentrations of CAPE (below the figures) for 72 h. Cells 
morphological changes were studied using inverted microscope 
(100X magnification). 0 µM represents control cells. As observed, 
CAPE induces cell death morphologically depending on treatment 
concentration. 
Progression steps of morphological changes induced by 
CAPE in AGS cells
To study progression steps of morphological changes 
more accurate up to the final lysis of cells, we investigated 
the cells treated with 60 µM of CAPE within a 72-h 
period once each 12 h. As illustrated in Figure 3, at early 
hours (until 24 h) of treatment, most cells exhibited a 
series of morphological changes including cell shrinkage 
and membrane blebbing (steps B to D respectively). 
As treatment continued up to 72 h, the cells exhibited 
a series of morphological changes including swelling 
of cytoplasm, plasma membrane destruction and cell 
disruption with intracellular components release and 
formation of apoptotic bodies, which ended with lysis of 
apoptotic bodies (steps E to H respectively).
Discussion
Cancerous cells are identified by uncontrolled cell growth 
and proliferation because of abnormal function of genes 
and proteins which are responsible for cell cycle regulation 
(22). In this study, we indicated that CAPE at very low 
concentrations obviously prevented AGS cells growth 
and proliferation by inducing cytotoxic effects. Also, 
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CAPE induced cell death in AGS cells through inducing 
morphological apoptotic changes in a concentration-
dependent manner.
CAPE antiproliferative activity on AGS cell line is similar 
with its biological activity in other carcinoma cell types. 
For example, CAPE prevents cell growth and proliferation 
in breast cancer (21), glioma (23), leukemia (24), oral 
cancer (25,26), and colorectal cancer (27). In contrast, 
some studies indicated that CAPE had no cytotoxic 
effects on non-tumoral cells including immortal breast 
cancer cells [MCF-7-10A (ER-)] and peripheral blood 
mononuclear cells (21-24).
Apoptosis has been greatly studied due to playing critical 
roles in embryogenesis and pathological processes. For 
cancer, apoptosis promoting has been considered as a 
strategy for discovering anticancer drugs (28). In this 
regard, studies on anticancer effects of CAPE indicated 
that this active propolis compound prevent cancerous cell 
growth through inducing apoptosis with no induction 
of cytotoxicity for healthy cells (20,21). Consistently, 
our findings in the present study indicated, for the first 
time, that CAPE at very low concentrations induced 
strong cytotoxic effects on AGS cells and also describing 
of morphological changes as an important approach to 
diagnosing apoptosis indicated that these cytotoxic effects 
are exerted through apoptosis induction.
The cells undergoing apoptosis have a series of 
morphological apoptotic specifications such as cell 
shrinkage, membrane blebbing, chromatin cleavage, 
nuclear condensation, and apoptotic body formation 
(11,29) which are the basis of many techniques to 
diagnose and quantify apoptosis and in this field this, 
inverted microscope is a valuable instrument to study 
morphological apoptotic specifications. As illustrated in 
Figure 3, microscopic investigation of AGS cells indicated 
cell shrinkage and membrane blebbing, and then increased 
blebbing which are considered as the morphological signs 
of primary apoptosis and known as a prenecrotic phase.
In some special apoptotic processes, apoptotic cells are 
removed by heterolytic degradation by phagocytes which 
is dependent on expression of eat-me signals [the most 
well known is phosphatidylserine (PS)] (30-33). Removal 
of apoptotic cells at this stage in multicellular organisms 
is an rule that is described by the term of efferocytosis 
and considered as a quick and safe approach to clearance 
apoptotic cells (34). An alternative and underestimated 
outcome of apoptosis is secondary necrosis which is an 
autolytic process of cell decomposition with cytoplasmic 
swelling, cytoplasm membrane destruction, and finally 
cell disruption and intracellular components release 
(35). In fact, progression of apoptosis into secondary 
necrosis and complete apoptotic program occurs when 
there are no phagocytes or scavengers (35). Cultured in 
vitro, as the conditions in our study, complete apoptotic 
program should occur because of lack of phagocytes 
and as illustrated in Figure 3, the AGS cells treated with 
CAPE passed prenecrotic phase and entered into necrotic 
phase (secondary necrosis). This stage was observed with 
cytoplasmic swelling and plasma membrane destruction 
(Figures 3E and 3F), cell fragmentation and formation of 
apoptotic bodies (Figure 3G), and finally lysis of apoptotic 
bodies (Figure 3H). These findings represent induction of 
complete apoptotic program in CAPE-treated AGS cells, 



















 Figure 3. Progression of induced apoptosis in AGS cells treated with CAPE; the cells treated with 60 µM of CAPE within a 72-h period were 
investigated morphologically once each 12 h. At early hours (until 24 h) of treatment, the cells underwent cell shrinkage and membrane 
blebbing (B to D). As investigation continued till 72 h, the cells exhibited cytoplasmic swelling (E), plasma membrane destruction (F), and 
cell disruption and formation of apoptotic bodies (G), which ended with lysis of apoptotic bodies (H).
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contrast to using the stains like trypan blue, naphthalene 
black, propidium iodide and ethidium bromide which 
differentiate living cells from non living and give a fast but 
crude estimate of dead versus live cells, microscopy is a 
much more valuable and accurate tool for the assessment 
of apoptosis permitting identification of the classical 
hallmarks of apoptosis such as cell shrinkage, membrane 
blebbing and formation of apoptotic bodies
Overall, our findings indicated that CAPE prevents 
growth and proliferation of AGS human gastric cancer 
cell line through inducing complete cell death program in 
vitro. Therefore, CAPE could be considered as a potential 
chemotherapeutic agent or an adjuvant for treating 
gastric cancer. Further research is needed to clarify the 
mechanisms of CAPE effect on apoptosis induction in 
gastric cancer.
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